Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...
For business individuals, the festive season presents an excellent opportunity to introduce new strategies or offers, which could potentially elevate your financial status. The demand for your ...
Hikma Pharmaceuticals PLC HIK shares inched down 0.94% to £19.02 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0. ...
Julia Kagan is a financial/consumer journalist and former ... Suriyawut Suriya / Getty Images Filing status is a category that defines the type of tax return form a taxpayer must use when filing ...
They can also check the share allotment status on the official websites of the NSE. Skyline Financial Services Private Ltd was the registrar for the issue. Step 1: Go to the website of Skyline ...
Financial Guidance Kiniksa expects 2024 ARCALYST ... ARCALYST was discovered by Regeneron Pharmaceuticals, Inc. (Regeneron) and is approved by the U.S. Food and Drug Administration (FDA) for ...
PRETORIA - The Gauteng government has raised a red flag about the R24-billion that's owed to the City of Tshwane. According to Gauteng Finance MEC Lebogang Maile, 70-percent of debtors are ...
The Nigeria-based fintech Moniepoint has gained “unicorn” status after raising $110mn ... one of a cohort of companies providing digital financial services in Africa’s most populous nation ...
Conference Call Information Kiniksa will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, October 29, 2024, to discuss third quarter 2024 financial results ... was discovered ...
Analysts said that such efforts will not only support Hong Kong's deep integration in AI and regulatory development but also further consolidate its status as an international financial hub.
Deneen Vojta, M.D., a seasoned physician and nationally recognized leader in health innovation, has been appointed executive vice president for Health Solutions at Blue Shield of California, effective ...
Chugai Pharmaceutical Co. has announced an upward revision in its financial forecasts for the fiscal year ending December 2024, reflecting significant changes in its business environment.